Literature DB >> 1560574

[Attenuation of cardiovascular response to laryngoscopy and tracheal intubation with bolus injection of diltiazem].

J Hasegawa1, H Mitsuhata, S Matsumoto, K Enzan.   

Abstract

Effect of diltiazem on cardiovascular response to laryngoscopy and tracheal intubation was studied in 20 patients without hypertension and 10 patients with hypertension to be operated on under general anesthesia. The patients were divided into three groups: the first group without hypertension (group C, n = 10) received saline as control, the second group without hypertension (group N, n = 10) received bolus injection of diltiazem, and the third group with hypertension (group H, n = 10) received bolus injection of diltiazem. Diltiazem was administered 2 min before intubation at a dose of 0.2 mg.kg-1 as a bolus injection. Changes of mean blood pressure, rate pressure product, pressure rate quotient in group H and N decreased significantly compared with group C. Changes of heart rate were comparable among the three groups. Complications were not remarkable except one case in which systolic pressure decreased to 80 mmHg. The results suggest that bolus injection of diltiazem at a dose of 0.2 mg.kg-1 attenuates cardiovascular response to laryngoscopy and tracheal intubation without serious complications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560574

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  2 in total

1.  Effects of calcium channel blockers on circulatory response to tracheal intubation in hypertensive patients: nicardipine versus diltiazem.

Authors:  Y Fujii; H Tanaka; Y Saitoh; H Toyooka
Journal:  Can J Anaesth       Date:  1995-09       Impact factor: 5.063

2.  Different doses of intravenous Magnesium sulfate on cardiovascular changes following the laryngoscopy and tracheal intubation: A double-blind randomized controlled trial.

Authors:  Azim Honarmand; Mohammadreza Safavi; Sajad Badiei; Neda Daftari-Fard
Journal:  J Res Pharm Pract       Date:  2015 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.